We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+4.2%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$216B
AUM Growth
+$23B
Cap. Flow
+$15.2B
Cap. Flow %
7.01%
Top 10 Hldgs %
16.18%
Holding
8,493
New
749
Increased
3,978
Reduced
2,659
Closed
707

Sector Composition

Rank Sector Weight
1 Financials 7.19%
2 Technology 6.4%
3 Healthcare 6.06%
4 Industrials 4.94%
5 Consumer Discretionary 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HIMX
3151
CALL
Himax Technologies
HIMX
$2.23B
$1.89M ﹤0.01%
173,000
-150,000
-46% -$1.36M
RARE icon
3152
Ultragenyx Pharmaceutical
RARE
$2.46B
$1.89M ﹤0.01%
35,420
+18,098
+104% +$1.07M
MMLP icon
3153
Martin Midstream Partners
MMLP
$95.9M
$1.88M ﹤0.01%
121,072
-11,441
-9% -$202K
UCTT
3154
Ultra Clean Holdings
UCTT
$4B
$1.88M ﹤0.01%
61,495
+59,602
+3,149% +$1.41M
OCLR
3155
DELISTED
Oclaro Inc.
OCLR
$1.88M ﹤0.01%
218,151
+50,005
+30% +$450K
SCLN
3156
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
$1.88M ﹤0.01%
168,059
+7,104
+4% +$78.4K
SFR
3157
DELISTED
Starwood Waypoint Homes
SFR
$1.88M ﹤0.01%
51,731
+8,356
+19% +$298K
AXTA icon
3158
CALL
Axalta
AXTA
$7.76B
$1.88M ﹤0.01%
+65,000
New +$1.96M
USPH icon
3159
US Physical Therapy
USPH
$1.18B
$1.88M ﹤0.01%
30,565
+1,442
+5% +$87.8K
UA icon
3160
PUT
Under Armour Class C
UA
$2.83B
$1.88M ﹤0.01%
+125,000
New +$2.1M
SBH icon
3161
Sally Beauty Holdings
SBH
$1.54B
$1.88M ﹤0.01%
95,884
+55,176
+136% +$1.08M
JPI
3162
DELISTED
Nuveen Preferred Securities & Income Opportunities Fund
JPI
$1.88M ﹤0.01%
74,493
+18,154
+32% +$452K
HGV icon
3163
Hilton Grand Vacations
HGV
$3.52B
$1.87M ﹤0.01%
48,528
-47,269
-49% -$1.71M
DATA
3164
PUT
DELISTED
Tableau Software, Inc.
DATA
$1.87M ﹤0.01%
25,000
K
3165
CALL
DELISTED
Kellanova
K
$1.87M ﹤0.01%
31,950
-14,271
-31% -$901K
PPG icon
3166
CALL
PPG Industries
PPG
$25.3B
$1.87M ﹤0.01%
+17,200
New +$1.83M
NBD
3167
DELISTED
Nuveen Build Am Bond Opp Fd
NBD
$1.87M ﹤0.01%
84,736
+4,334
+5% +$96.1K
GEUR
3168
DELISTED
AdvisorShares Gartman Gold/Euro ETF
GEUR
$1.87M ﹤0.01%
161,115
+19,536
+14% +$227K
FTV icon
3169
PUT
Fortive
FTV
$18B
$1.86M ﹤0.01%
41,706
+40,913
+5,159% +$1.7M
SR icon
3170
Spire
SR
$4.73B
$1.86M ﹤0.01%
24,913
+2,179
+10% +$162K
XLVS
3171
DELISTED
POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO
XLVS
$1.86M ﹤0.01%
19,998
+3,427
+21% +$318K
TREE icon
3172
LendingTree
TREE
$448M
$1.85M ﹤0.01%
7,565
+4,674
+162% +$1.01M
FHLC icon
3173
Fidelity MSCI Health Care Index ETF
FHLC
$3.28B
$1.85M ﹤0.01%
46,793
+9,562
+26% +$370K
ASTE icon
3174
Astec Industries
ASTE
$1.21B
$1.85M ﹤0.01%
32,956
+341
+1% +$17.4K
BFX
3175
DELISTED
BowFlex Inc.
BFX
$1.84M ﹤0.01%
109,121
+6,376
+6% +$110K

Similar funds

UBS Group's Q3 2017 Portfolio in Review

As of Q3 2017, UBS Group held 8,493 positions worth $216B, up 12% from $193B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group deployed $15.2B of net new capital in Q3 2017, opening 749 new positions and adding to 3,978 existing holdings. Its largest new stake was Baker Hughes: 613,477 shares worth $22.5M.

By sector, the portfolio is most concentrated in Financials at 7.2% of assets, down from 7.7% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Monsanto Co, an estimated $658M trimmed.

  • UBS Group's largest Q3 2017 buy was Baker Hughes: 613,477 shares worth $22.5M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $422M increase.
  • UBS Group's biggest Q3 2017 reduction was Monsanto Co, cutting an estimated $658M.
  • UBS Group fully exited Oneok Partners LP in Q3 2017, selling an estimated $218M.
  • UBS Group's ten largest holdings make up 16% of its $216B portfolio in Q3 2017.
  • UBS Group opened 749 new positions and closed 707 in Q3 2017.
  • UBS Group's portfolio value rose 12% quarter-over-quarter to $216B.

Based on UBS Group's 13F filing for Q3 2017, filed 14 Nov 2017.